Vident Investment Advisory LLC bought a new position in shares of Clorox Co (NYSE:CLX) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 11,199 shares of the company’s stock, valued at approximately $1,477,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Jacobi Capital Management LLC increased its position in Clorox by 0.3% during the 2nd quarter. Jacobi Capital Management LLC now owns 1,286 shares of the company’s stock worth $172,000 after purchasing an additional 4 shares in the last quarter. Valley National Advisers Inc. increased its position in Clorox by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after purchasing an additional 5 shares in the last quarter. Bernzott Capital Advisors increased its position in Clorox by 0.4% during the 2nd quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after purchasing an additional 7 shares in the last quarter. Financial Advisory Service Inc. increased its position in Clorox by 0.3% during the 2nd quarter. Financial Advisory Service Inc. now owns 4,012 shares of the company’s stock worth $535,000 after purchasing an additional 12 shares in the last quarter. Finally, Moors & Cabot Inc. increased its position in Clorox by 1.2% during the 2nd quarter. Moors & Cabot Inc. now owns 2,557 shares of the company’s stock worth $339,000 after purchasing an additional 30 shares in the last quarter. 73.42% of the stock is owned by hedge funds and other institutional investors.

A number of analysts recently issued reports on the stock. Jefferies Group reissued a “hold” rating and set a $130.00 target price on shares of Clorox in a research report on Wednesday. Wells Fargo & Company reissued a “hold” rating and set a $130.00 target price on shares of Clorox in a research report on Wednesday. Deutsche Bank initiated coverage on shares of Clorox in a research report on Wednesday. They set a “hold” rating for the company. Consumer Edge raised shares of Clorox from a “neutral” rating to an “outperform” rating in a research report on Friday, November 10th. Finally, Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $128.67.

Shares of Clorox Co (NYSE:CLX) opened at $146.61 on Thursday. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. Clorox Co has a 1 year low of $115.00 and a 1 year high of $147.38. The stock has a market cap of $18,900.00, a P/E ratio of 26.15, a price-to-earnings-growth ratio of 3.95 and a beta of 0.43.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter last year, the company earned $1.36 earnings per share. Clorox’s revenue for the quarter was up 4.0% on a year-over-year basis. equities research analysts forecast that Clorox Co will post 5.6 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is currently 61.65%.

In other news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the transaction, the senior vice president now directly owns 10,896 shares in the company, valued at approximately $1,421,492.16. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “11,199 Shares in Clorox Co (CLX) Purchased by Vident Investment Advisory LLC” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/12/14/11199-shares-in-clorox-co-clx-purchased-by-vident-investment-advisory-llc.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Stock Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related stocks with our FREE daily email newsletter.